Journal of Diagnostics Concepts & Practice >
Change and significance of clinical indices on treatment with tacrolimus combined with piperazine ferulate for primary nephrotic syndrome in elderly
Received date: 2018-09-20
Online published: 2019-02-25
Objective: To observe the change of clinical indicesontreatment with tacrolimus combined with piperazine ferulate in elderly patients with primary nephrotic syndrome. Methods: Fifty elderly patients with primary nephrotic syndrome were randomly divided into combined therapy group (25 case) and the single therapy group (25 case) to be treated with tacrolimus combined with piperazine ferulate or single tacrolimus for 6 months, respectively. The changes of indices includedserum triglyceride, cholesterol, albumin, creatinine, urea nitrogen, urine protein andtherapeutic efficacy; the two groups were compared. Theadverse reactions were also compared. Results: The overall therapeutic efficacy of combined therapy group and single therapy group were 84% and 72%, respectively (P<0.05). The combined therapy group showed better improvement in serum albumin [(39.9±1.9) g/L vs (34.6±2.1) g/L] and urine protein [(2.5±0.9) g vs (3.6±1.0) g](P<0.05). Adverse reactions showed no significant difference between the combined therapy group and single therapy group(12% vs 8%, P>0.05). Conclusions: Tacrolimus combined with piperazine ferulate is better than tacrolimus only for the treatment of primary nephrotic syndrome in elderly patients without increase inadverse reactions.
JIAO Jieru, LI Yanran, CHEN Xiaonong, LIN Qing . Change and significance of clinical indices on treatment with tacrolimus combined with piperazine ferulate for primary nephrotic syndrome in elderly[J]. Journal of Diagnostics Concepts & Practice, 2019 , 18(1) : 104 -106 . DOI: 10.16150/j.1671-2870.2019.01.021
[1] | 王海燕. 肾脏病学[M]. 2版. 北京: 人民卫生出版社, 1998. |
[2] | 孙雪梅, 陈香美. 他克莫司在原发性肾病综合征治疗中的应用[J]. 中国实用内科杂志, 2008, 28(5):323-325. |
[3] | 孙玉平, 史国兵, 樊蓉, 等. 他克莫司致不良反应67例文献分析[J]. 医药导报, 2014, 33(11):1535-1537. |
[4] | 伊娜, 曹式丽. 老年原发性肾病综合征病机特点及证治[J]. 实用中医内科杂志, 2009, 23(1):44-45. |
[5] | 张亚莉, 余晓洋, 冯婕, 等. 老年原发性局灶性节段性肾小球硬化的临床及病理特点[J]. 中国老年学杂志, 2016, 36(17):4303-4305. |
[6] | Davin JC. The glomerular permeability factors in idiopathic nephrotic syndrome[J]. Pediatr Nephrol, 2016, 31(2):207-215. |
[7] | Dorval G, Gribouval O, Martinez-Barquero V, et al. Clini-cal and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome[J]. Pediatr Nephrol, 2018, 33(3):473-483. |
[8] | Birdwell KA, Decker B, Barbarino JM, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing[J]. Clin Pharmacol Ther, 2015, 98(1):19-24. |
[9] | 郭玉麟, 钟三保. 阿魏酸哌嗪的合成及其药理与临床研究[J]. 华西药学杂志, 1987, 2(1):52-54. |
/
〈 |
|
〉 |